鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/11/13 | 3,095 | 3,100 | 3,040 | 3,085 | -30 | -1% | 36,800 |
2017/11/10 | 3,070 | 3,120 | 3,070 | 3,115 | -10 | -0.3% | 20,200 |
2017/11/09 | 3,105 | 3,130 | 3,085 | 3,125 | +45 | +1.5% | 44,200 |
2017/11/08 | 3,035 | 3,085 | 3,035 | 3,080 | +15 | +0.5% | 12,900 |
2017/11/07 | 3,070 | 3,070 | 3,035 | 3,065 | -5 | -0.2% | 33,800 |
2017/11/06 | 3,060 | 3,075 | 3,035 | 3,070 | +10 | +0.3% | 17,900 |
2017/11/02 | 3,055 | 3,065 | 3,035 | 3,060 | ±0 | ±0% | 20,700 |
2017/11/01 | 3,070 | 3,075 | 3,040 | 3,060 | -10 | -0.3% | 21,400 |
2017/10/31 | 3,080 | 3,080 | 3,040 | 3,070 | +30 | +1% | 30,900 |
2017/10/30 | 3,095 | 3,115 | 3,025 | 3,040 | -55 | -1.8% | 60,100 |
2017/10/27 | 3,020 | 3,115 | 3,020 | 3,095 | -65 | -2.1% | 74,200 |
2017/10/26 | 3,140 | 3,180 | 3,115 | 3,160 | +5 | +0.2% | 35,000 |
2017/10/25 | 3,220 | 3,225 | 3,150 | 3,155 | -95 | -2.9% | 40,300 |
2017/10/24 | 3,200 | 3,250 | 3,190 | 3,250 | +60 | +1.9% | 43,000 |
2017/10/23 | 3,180 | 3,195 | 3,165 | 3,190 | +10 | +0.3% | 20,600 |
2017/10/20 | 3,150 | 3,195 | 3,150 | 3,180 | +20 | +0.6% | 19,900 |
2017/10/19 | 3,145 | 3,180 | 3,145 | 3,160 | -5 | -0.2% | 21,300 |
2017/10/18 | 3,225 | 3,225 | 3,150 | 3,165 | -50 | -1.6% | 42,000 |
2017/10/17 | 3,205 | 3,225 | 3,170 | 3,215 | +5 | +0.2% | 35,200 |
2017/10/16 | 3,190 | 3,240 | 3,190 | 3,210 | +5 | +0.2% | 29,700 |
2017/10/13 | 3,165 | 3,215 | 3,165 | 3,205 | +15 | +0.5% | 31,900 |
2017/10/12 | 3,170 | 3,205 | 3,165 | 3,190 | +35 | +1.1% | 21,400 |
2017/10/11 | 3,170 | 3,170 | 3,150 | 3,155 | -5 | -0.2% | 18,100 |
2017/10/10 | 3,180 | 3,180 | 3,150 | 3,160 | -20 | -0.6% | 19,300 |
2017/10/06 | 3,215 | 3,230 | 3,165 | 3,180 | -40 | -1.2% | 76,000 |
2017/10/05 | 3,195 | 3,225 | 3,190 | 3,220 | +5 | +0.2% | 25,400 |
2017/10/04 | 3,170 | 3,235 | 3,155 | 3,215 | +30 | +0.9% | 37,200 |
2017/10/03 | 3,180 | 3,200 | 3,130 | 3,185 | +15 | +0.5% | 39,300 |
2017/10/02 | 3,170 | 3,190 | 3,160 | 3,170 | -30 | -0.9% | 35,100 |
2017/09/29 | 3,240 | 3,255 | 3,170 | 3,200 | -40 | -1.2% | 63,400 |
2017/09/28 | 3,455 | 3,455 | 3,230 | 3,240 | +205 | +6.8% | 206,400 |
2017/09/27 | 3,010 | 3,035 | 2,999 | 3,035 | +15 | +0.5% | 17,000 |
2017/09/26 | 2,995 | 3,025 | 2,995 | 3,020 | ±0 | ±0% | 19,500 |
2017/09/25 | 3,025 | 3,045 | 2,973 | 3,020 | +15 | +0.5% | 47,200 |
2017/09/22 | 3,000 | 3,015 | 2,973 | 3,005 | +29 | +1% | 25,200 |
2017/09/21 | 3,000 | 3,020 | 2,972 | 2,976 | -34 | -1.1% | 19,600 |
2017/09/20 | 2,970 | 3,035 | 2,958 | 3,010 | +50 | +1.7% | 39,500 |
2017/09/19 | 2,974 | 2,974 | 2,918 | 2,960 | +20 | +0.7% | 25,400 |
2017/09/15 | 2,946 | 2,956 | 2,922 | 2,940 | +17 | +0.6% | 43,800 |
2017/09/14 | 2,936 | 2,945 | 2,912 | 2,923 | +11 | +0.4% | 27,400 |
2017/09/13 | 2,912 | 2,936 | 2,903 | 2,912 | -12 | -0.4% | 13,300 |
2017/09/12 | 2,900 | 2,925 | 2,893 | 2,924 | +43 | +1.5% | 23,600 |
2017/09/11 | 2,888 | 2,906 | 2,869 | 2,881 | +41 | +1.4% | 19,100 |
2017/09/08 | 2,826 | 2,860 | 2,826 | 2,840 | ±0 | ±0% | 25,100 |
2017/09/07 | 2,857 | 2,876 | 2,826 | 2,840 | +4 | +0.1% | 26,900 |
2017/09/06 | 2,789 | 2,846 | 2,750 | 2,836 | +43 | +1.5% | 30,600 |
2017/09/05 | 2,875 | 2,878 | 2,791 | 2,793 | -81 | -2.8% | 31,100 |
2017/09/04 | 2,958 | 2,958 | 2,874 | 2,874 | -84 | -2.8% | 22,700 |
2017/09/01 | 2,956 | 2,964 | 2,928 | 2,958 | +1 | ±0% | 19,100 |
2017/08/31 | 2,961 | 2,981 | 2,937 | 2,957 | +3 | +0.1% | 20,900 |
1901~
1950
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
キッセイ薬 | 429,500円 | +3.6% | - | 2.79% | 14.47倍 | 0.86倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ペプチド | 153,600円 | +5.0% | +1.5% | 0.00% | 13.15倍 | 3.70倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,600円 | - | - | 0.00% | - | 110.98倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 382,600円 | -6.4% | -71.8% | 4.97% | 42.61倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム